Tryton Medical introduces Side Branch Stent System in Europe

Tryton’s Side Branch Stent System is designed to offer a dedicated strategy for treating atherosclerotic lesions at the site of a bifurcation. The system will be available first in the Netherlands, with additional European countries to follow in the coming months. Top Medical has partnered with Tryton to distribute the device in the Netherlands.

Tryton’s cobalt chromium stent is deployed in the side branch artery using a standard single-wire balloon-expandable stent delivery system. A conventional drug eluting stent is then placed in the main vessel.

The Tryton Side Branch Stent System demonstrated excellent six-month clinical results in a first-in-man study of the system in 30 patients, with no restenosis occurring in the side-branch artery. The stent system has received CE mark approval in Europe and is not approved in the US.

Greg Davis, president and CEO of Tryton Medical, said: “We are excited about the benefits that our technology promises for patients with cardiovascular disease in Europe. We plan to launch in additional countries soon. We also look forward to initiating a multi-center prospective study evaluating the Tryton Side Branch Stent in real-life practice in the coming weeks.”